Last reviewed · How we verify

NCT05809570

Periodontal Disease Prediction System

Completed Last updated 14 April 2023
What this trial tests

trial testing Clinical examination in Periodontal Diseases in 1,057 participants. Completed in 1 June 2022.

Timeline
1 June 2020
Primary endpoint
1 January 2022
1 June 2022

Quick facts

Lead sponsorBezmialem Vakif University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment1,057
Start date1 June 2020
Primary completion1 January 2022
Estimated completion1 June 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Bezmialem Vakif University

Who can join

18 and older, any sex, with Periodontal Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study was to develop a periodontal disease prediction software and a patient-based gingival recession simulator for clinical practice aiming at improving oral hygiene motivation of patients with periodontal problems.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Clinical examination

Trials testing the same drug.

Other recruiting trials for Periodontal Diseases

Currently open trials in the same condition.

Other Bezmialem Vakif University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05809570.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing